A distributor reported on behalf of the customer that a (b)(6) year-old male patient was implanted with the 909712 osvii connector with antechamber as treatment of hydrocephalus on (b)(6) 2018.The patient then presented with symptoms of intracranial hypertension in (b)(6) 2018.A resonance examination revealed hypertension with ventricular enlargement.On (b)(6) 2019, the team opted for withdrawal of the system and it was replaced with the strata programmable valve.According to the doctor¿s report, both catheters (proximal and distal) were unobstructed.Additional information was received on (b)(6) 2019 indicating that the patient was well after the device replacement procedure.
|
The device history records review did not reveal any anomaly that could explain the reported event.No similar complaint was received for a product from this batch.The valve was tested and found within pressure/flow specifications.The complaint is not verified.Patient presented with intracranial hypertension 4 months after implantation: given the valve testing results, it is possible that the valve was not draining enough for the patient needs, or the valve was indeed obstructed by some residues that were displaced during further valve manipulations (explantation, decontamination or transport).The exact cause of the reported underdrainage could not be determined by the investigation.Device identifier (b)(4).
|